Gara Jalqabaatti › Leukemia Biphenotypicii Hamaa › Minnesota
Qorannoo klinikaalii Leukemia Biphenotypicii Hamaa Minnesota keessatti
Qorannoo 6 Leukemia Biphenotypicii Hamaa f Minnesota keessatti hirmaatuu jiru.
Magaalota Minnesota keessatti
Takkalaa qorannoo (Ingiliffa)
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
- University of Minnesota/Masonic Cancer Center, Minneapolis
Namoota walitti qabaa jiraSadarkaa 2
365 Days · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06317662Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
- University of Minnesota/Masonic Cancer Center, Minneapolis
- Mayo Clinic in Rochester, Rochester
Namoota walitti qabaa jiraSadarkaa 3
365 Days – 25 Years · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT03959085The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
- University of Minnesota/Masonic Cancer Center, Minneapolis
- Mayo Clinic in Rochester, Rochester
Namoota walitti qabaa jiraSadarkaa 1/2
Hanga umuriin 22 · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT04726241Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
- Mayo Clinic, Clinical Trials Referral Office, Rochester
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 13 hanga 90 · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT06533579Allo HSCT Using RIC and PTCy for Hematological Diseases
- Masonic Cancer Center at University of Minnesota, Minneapolis
Namoota walitti qabaa jiraSadarkaa 2
Hanga umuriin 75 · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT05805605Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Children's Hospital and Clinics of Minnesota, Minneapolis
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 1 hanga 21 · Saalaa hunda · Haaromfame 06-Mud-2024 · NCT05476770Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.